BioSyent Inc. (BIOYF)
OTCMKTS · Delayed Price · Currency is USD
8.85
+0.19 (2.19%)
Aug 29, 2025, 11:56 AM EDT
BioSyent Revenue
BioSyent had revenue of 10.18M CAD in the quarter ending June 30, 2025, with 13.80% growth. This brings the company's revenue in the last twelve months to 39.51M, up 16.82% year-over-year. In the year 2024, BioSyent had annual revenue of 35.03M with 10.89% growth.
Revenue (ttm)
39.51M CAD
Revenue Growth
+16.82%
P/S Ratio
3.41
Revenue / Employee
n/a
Employees
n/a
Market Cap
98.89M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 35.03M | 3.44M | 10.89% |
Dec 31, 2023 | 31.59M | 3.67M | 13.12% |
Dec 31, 2022 | 27.93M | -693.03K | -2.42% |
Dec 31, 2021 | 28.62M | 6.29M | 28.15% |
Dec 31, 2020 | 22.33M | 907.84K | 4.24% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |
BioSyent News
- 3 days ago - BioSyent Inc. (BIOYF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - BioSyent declares CAD 0.05 dividend - Seeking Alpha
- 10 days ago - BioSyent Releases Financial Results for Q2 and H1 2025 - GlobeNewsWire
- 10 days ago - BioSyent Declares Third Quarter 2025 Dividend - GlobeNewsWire
- 17 days ago - BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025 - GlobeNewsWire
- 3 months ago - BioSyent Inc. (BIOYF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioSyent declares CAD 0.05 dividend - Seeking Alpha
- 3 months ago - BioSyent Releases Financial Results for First Quarter 2025 - GlobeNewsWire